Review article · 2022 · Open access
A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021
JAC-Antimicrobial Resistance, 4(1), dlac013 · Published 27 January 2022 · DOI 10.1093/jacamr/dlac013
In brief
“A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021” is a 2022 review article by Mandy Lau and 5 co-authors, published in JAC-Antimicrobial Resistance. OpenAlex counts 12 citations as of 19 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at JAC-Antimicrobial Resistance.
- Citations
- 12
- Most cited in
- 2023 (3)
- Field-weighted impact
- 0.26
- References
- 55
- Authors
- 6
Abstract
INTRODUCTION: Antimicrobial stewardship interventions (ASIs) aim to reduce the emergence of antimicrobial resistance. We sought to systematically evaluate how microbiological outcomes have been handled and analysed in randomized controlled trials (RCTs) evaluating ASIs. METHODS: We searched PubMed and Embase from 2011-21. Studies were selected if they were RCTs evaluating ASIs. A narrative synthesis approach was taken, identifying whether the study reported any microbiological data (bacterial genus/species; bacterial colony counts; prevalence of bacterial, microbiologically defined infections; and antibiotic susceptibility, measured pre-randomization or post-randomization in one arm only) or outcomes (post-randomization data compared between arms). Studies with or without microbiological data/outcomes were summarized in terms of study characteristics, methods of reporting and analysis of these outcomes. RESULTS: We identified 117 studies, with 34 (29.1%) collecting microbiological data and 18 (15.4%) reporting microbiological outcomes. Most studies with microbiological outcomes were conducted in secondary care (12/18, 66.7%) and targeted adult populations (14/18, 77.8%), and the intervention involved biomarker-guided rapid diagnostic testing (7/18, 38.9%). The overall quality of reporting and analysing microbiological outcomes was low and inconsistent. The selected study population in analyses and methods of handling missing data were unclear. CONCLUSIONS: This review demonstrates that the quality of handling and reporting microbiological outcomes in RCTs of ASIs was low. The lack of consistency and clarity made it difficult to compare the findings across studies, limiting policy- and clinical decision-making. Therefore, there is a clear need for the development of guidance for handling microbiological outcomes in RCTs and adopting appropriate methods to evaluate these data carefully.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lau, M., Daniel, R., Hughes, K., Wootton, M., Hood, K., & Gillespie, D. (2022). A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021. JAC-Antimicrobial Resistance, 4(1), dlac013. https://doi.org/10.1093/jacamr/dlac013
MLA 9
Lau, Mandy, et al. “A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021.” JAC-Antimicrobial Resistance, vol. 4, no. 1, 2022, p. dlac013. https://doi.org/10.1093/jacamr/dlac013.
Chicago
Lau, Mandy, Rhian Daniel, Kathryn Hughes, Mandy Wootton, Kerenza Hood, and David Gillespie. 2022. “A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021.” JAC-Antimicrobial Resistance 4 (1): dlac013. https://doi.org/10.1093/jacamr/dlac013.
Harvard
Lau, M. et al. (2022) ‘A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021’, JAC-Antimicrobial Resistance, 4(1), p. dlac013. doi:10.1093/jacamr/dlac013.
IEEE
M. Lau, R. Daniel, K. Hughes, M. Wootton, K. Hood, and D. Gillespie, “A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021,” JAC-Antimicrobial Resistance, vol. 4, no. 1, p. dlac013, 2022, doi: 10.1093/jacamr/dlac013.
BibTeX
@article{lau2022systematic,
title = {{A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021}},
author = {Lau, Mandy and Daniel, Rhian and Hughes, Kathryn and Wootton, Mandy and Hood, Kerenza and Gillespie, David},
journal = {JAC-Antimicrobial Resistance},
year = {2022},
volume = {4},
number = {1},
pages = {dlac013},
doi = {10.1093/jacamr/dlac013},
url = {https://doi.org/10.1093/jacamr/dlac013}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 3 | |
| 2024 | 2 | |
| 2025 | 3 | |
| 2026 | 3 |
Its field-weighted citation impact is 0.26: it has been cited 0.26 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- microbiological outcomes
- randomized controlled trials
- antimicrobial resistance
- antibiotic susceptibility
- bacterial colony count
- rapid diagnostic tests
- reporting quality
- secondary care
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Lau, M., Daniel, R., Hughes, K., Wootton, M., Hood, K., & Gillespie, D. (2022). A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021. JAC-Antimicrobial Resistance, 4(1), dlac013. https://doi.org/10.1093/jacamr/dlac013
How many times has this paper been cited?
12 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at JAC-Antimicrobial Resistance: sign in and open the PDF from this page.
Who wrote this paper?
Mandy Lau, Rhian Daniel, Kathryn Hughes, Mandy Wootton, Kerenza Hood, David Gillespie.
What is the DOI of this paper?
10.1093/jacamr/dlac013, permanently at https://doi.org/10.1093/jacamr/dlac013. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.